MEET KASHIF

Kashif had been running The DNA Company, a DNA testing company that works with doctors and clinicians to analyze their patients’ DNA.

However, Kashif wanted to diversify their product offering and reach a new market. So they needed to do a few things: hone in on their D2C market and gain ecommerce knowhow.

Kashif contemplated outsourcing this to a consulting group. But then he found Start & Scale.

After taking the course with his team members, they were able to develop and successfully scale their D2C product: reports on mood and behavior, cardiovascular health, and hormonal cycles for men and women.

In a few months, The DNA Company went from the research phase to gaining $400,000 in revenue from this product offering.

This is going to turn into a $10 million plus business for us.

It wasn’t long until the world began experiencing the COVID-19 pandemic. In the midst of global chaos, IBM Watson, an artificial intelligence computing company, approached Kashif to combine and apply their data to better determine who is more predisposed to hospital visits for COVID-19.

If it hadn’t been for the ecommerce offering, we would’ve never been able to fund the COVID-19 project with IBM.

While the initiative was completely free, it thrust The DNA Company into the public eye. As a result, governments like Switzerland and United States approached the business to implement the product into their healthcare systems.